EGFR and lung adenocarcinoma: In addition, Wu et al screened 1476 lncRNAs dysregulated in EGFR-TKI-resistant cell line of lung adenocarcinoma, which further illustrated lncRNAs may play as biomarkers in EGFR-TKI therapy [82].